Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Emiel De Jaeghere

Work address: C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent
Email: Emiel.DeJaeghere@UGent.be
ORCID iD: 0000-0001-6314-6179

Show Sort by

Add to list
- Journal Article
- A1
- open access
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort

Axel Van Damme (UGent) , Julie Rombaut (UGent) , Amin Makar (UGent) , Emiel De Jaeghere (UGent) , Eline Naert (UGent) , Hannelore Denys (UGent) , Rawand Salihi (UGent) , Philippe Tummers (UGent) and Katrien Vandecasteele (UGent)

(2023) WORLD JOURNAL OF SURGICAL ONCOLOGY. 21(1).
Add to list
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188
Add to list
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2022) CANCER IMMUNOLOGY IMMUNOTHERAPY.
Add to list
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Roos Colman (UGent) , Wim Schrauwen (UGent) , Paulien West (UGent) , Nele Vandemaele (UGent) , Aglaja De Pauw (UGent) , Celine Jacobs (UGent) , Ingeborg Hilderson, Michael Saerens (UGent) , et al.

(2022) CANCERS. 14(4).
Add to list
- Conference Paper
- C3
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450
Add to list
- Journal Article
- A1
- open access
Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis

Michael Saerens (UGent) , Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Nele Vandemaele (UGent) , Hannelore Denys (UGent) and Eline Naert (UGent)

(2021) CANCERS. 13(18).
Add to list
How are OCD patients and family members dealing with the waxing and waning pattern of the COVID-19 pandemic? Results of a longitudinal observational study

Hannelore Tandt (UGent) , Inge Debruyckere (UGent) , Lemke Leyman (UGent) , Roos Colman (UGent) , Emiel De Jaeghere (UGent) , Hanna Van Parys (UGent) , Chris Baeken (UGent) , Christine Purdon and Gilbert Lemmens (UGent)

(2021) PSYCHIATRIC QUARTERLY. 92(4). p.1549-1563
Add to list
Splenic hematopoietic and stromal cells in cancer progression

Jonas Steenbrugge (UGent) , Emiel De Jaeghere (UGent) , Evelyne Meyer (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2020) CANCER RESEARCH. 81(1). p.27-34
Add to list
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo (UGent) , Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343
Add to list
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Sofie De Geyter (UGent) , Koen Van de Vijver (UGent) , An Hendrix (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2020) International Journal of Cancer.

1
2
3

Next →